A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

Vasilev, Krasimir ; Reshedko, Galina ; Orasan, Remus ; Sanchez, Miguel ; Teras, Juri ; Babinchak, Tim ; Dukart, Gary ; Cooper, Angel ; Dartois, Nathalie ; Gandjini, Hassan ; Orrico, Russ ; Ellis-Grosse, Evelyn

Journal of antimicrobial chemotherapy, 2008-09, Vol.62 (suppl-1), p.i29-i40 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível